For research use only. Not for therapeutic Use.
Emylcamate (Cat.No:I006662) is a pharmaceutical compound that was once used as a sedative and hypnotic agent. However, due to its potential for adverse effects and limited therapeutic benefits, its use has declined over the years. Emylcamate’s main mechanism of action involves enhancing the inhibitory effects of the neurotransmitter GABA in the brain.
| Catalog Number | I006662 |
| CAS Number | 78-28-4 |
| Synonyms | Emylcamate; Emilcamato; Emylcamat; Nuncital; Psicoplegil; Restetal; Stratran; Striatan; Striatran; Statran; KABI-925; Kabi-295; tert-Hexyl carbamate; MK-250.;1-Ethyl-1-methylpropyl carbamate |
| Molecular Formula | C7H15NO2 |
| Purity | ≥95% |
| Solubility | Soluble in DMSO, not in water |
| Storage | 0 - 4°C for short term or -20 °C for long term |
| IUPAC Name | 3-methylpentan-3-yl carbamate |
| InChI | InChI=1S/C7H15NO2/c1-4-7(3,5-2)10-6(8)9/h4-5H2,1-3H3,(H2,8,9) |
| InChIKey | SLWGJZPKHAXZQL-UHFFFAOYSA-N |
| SMILES | CCC(C)(CC)OC(=O)N |
| Reference | </br>1:Long-term treatment of alcoholism with amitriptyline and emylcamate. A double-blind evaluation. Charnoff SM.Q J Stud Alcohol. 1967 Jun;28(2):289-94. No abstract available. PMID: 4860508 </br>2:[THE ORTHONEUROTIC EMYLCAMATE IN DAILY PRACTICE]. DARBELLAY J.Brux Med. 1963 Oct 6;43:1009-19. French. No abstract available. PMID: 14052966 </br>3:A STUDY OF A NEW TRANQUILIZER IN GENERAL PRACTICE: EMYLCAMATE IN 400 PATIENTS. SHUBIN H, STEINBERG N.Curr Ther Res Clin Exp. 1963 Oct;5:527-33. No abstract available. PMID: 14074232 </br>4:[Effect of meprobamate and emylcamate on human performance in a prolonged serial task]. BERTELSON P, JOFFE R.Psychopharmacologia. 1962 Oct 5;3:242-53. French. No abstract available. PMID: 13966735 </br>5:Emylcamate in hospitalized mentally retarded spastic patients. CARTER CH.Dis Nerv Syst. 1962 Apr;23:211-6. No abstract available. PMID: 13876949 </br>6:Emylcamate–its use in orthopedic practice. MANDARINO MP.Arch Surg. 1961 Aug;83:296-9. No abstract available. PMID: 13766048 </br>7:Influence of emylcamate, meprobamate, and placebo on psychologic test performance. JONSSON CO, ANDERSEN K.Clin Pharmacol Ther. 1960 Nov-Dec;1:708-15. No abstract available. PMID: 13790642 </br>8:Behavioral toxicity of emylcamate (striatran). UHR L, MILLER JG.Am J Med Sci. 1960 Aug;240:197-203. No abstract available. PMID: 14405494 </br>9:Experimentally determined effects of emylcamate (striatran) on performance, autonomic response, and subjective reactions under stress. UHR L, MILLER JG.Am J Med Sci. 1960 Aug;240:204-12. No abstract available. PMID: 13779033 </br>10:Clinical trial of emylcamate, a new internuncial blocking tranquilizer. A double-blind study in alcoholic out-patients. MARTENS S.Q J Stud Alcohol. 1960 Jun;21:223-32. No abstract available. PMID: 14421603 |
